investordatabase.org

CEPI (Coalition for Epidemic Preparedness Innovations)

cepi.net Direct investor

CEPI is a global partnership between public, private, philanthropic and civil organisations that funds and coordinates development of vaccines and biologic countermeasures against epidemic and pandemic threats. It has committed up to $3.6 billion in R&D and manufacturing projects since its 2017 launch.

CEPI (Coalition for Epidemic Preparedness Innovations) is a public fund headquartered in Oslo, Norway, founded in 2017. It invests directly in companies, in vaccines, biologics, epidemic and pandemic preparedness and RNA technology. 75 portfolio companies, as it reports.

“CEPI is working to galvanise the development of new vaccines and other biologic countermeasures against diseases that could cause the next devastating epidemic or pandemic.”

— CEPI (Coalition for Epidemic Preparedness Innovations), own website
Layer
Direct investor
Type
Public fund
Stage
Not stated
Headquarters
Oslo, Norway
Invests in
global
Sectors
vaccines, biologics, epidemic and pandemic preparedness, RNA technology, manufacturing
Founded
2017
Portfolio
75 companies

Team, as CEPI (Coalition for Epidemic Preparedness Innovations) publishes it

  • Richard Hatchett CEO

Names and roles exactly as listed on cepi.net. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page CEPI (Coalition for Epidemic Preparedness Innovations) publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 13876 · added 2026-10-19 · link last verified 2026-10-21 · confidence high

Similar investors

Listed under